Yahoo Finance • 12 months ago

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced will present at the Pipe... Full story

Yahoo Finance • 12 months ago

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

Third quarter 2023 revenue of $16.4 million, an increase of 47% year-over-year Full-year revenue guidance increased to $62.5-$63.5 million, up from $59-$61 million Cash burn reduced to $2.2 million in the third quarter of 2023, relative... Full story

Yahoo Finance • last year

12 Best Performing NASDAQ Stocks in 2023

In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023. If you want to skip our introduction to the NASDAQ's performance this year and the broader stock market, then read 5 Best Performing NASDAQ Stocks in 2023.... Full story

Yahoo Finance • last year

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

- Upgraded nSight Platform Improves Clinicians’ Ability to Track, Review and Evaluate Patient Data - - ‘Simple Set Programming’ Enables Complete Programming Set Transfer Directly to RNS Tablet - - FDA Approval of Smaller, Portable and Si... Full story

Yahoo Finance • last year

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial... Full story

Yahoo Finance • last year

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

MOUNTAIN VIEW, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced participation in a fire... Full story

Yahoo Finance • last year

NeuroPace to Participate in Upcoming Investor Conferences

- Wells Fargo 2023 Healthcare Conference - - Morgan Stanley 21st Annual Global Healthcare Conference - - Lake Street Capital Markets 7th Annual Best Ideas Growth Conference - MOUNTAIN VIEW, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Ne... Full story

Yahoo Finance • last year

NeuroPace Announces CEO Transition

NeuroPace Appoints Joel Becker as President & CEO Becker Brings a Track Record of Strong Commercial Execution and Deep Medical Device Operating Expertise Mike Favet to leave Company after four years as President, CEO and Board Member and... Full story

Yahoo Finance • 2 years ago

NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023

MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financia... Full story

Yahoo Finance • 2 years ago

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participatin... Full story

Yahoo Finance • 2 years ago

NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results

MOUNTAIN VIEW, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for th... Full story

Yahoo Finance • 2 years ago

NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial... Full story

Yahoo Finance • 2 years ago

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors

MOUNTAIN VIEW, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced preliminary, unaudited r... Full story

Yahoo Finance • 2 years ago

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating... Full story

Yahoo Finance • 2 years ago

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating... Full story

Yahoo Finance • 2 years ago

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022

MOUNTAIN VIEW, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial... Full story

Yahoo Finance • 2 years ago

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference      

MOUNTAIN VIEW, Calif. , Aug. 23, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participatin... Full story

Yahoo Finance • 2 years ago

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

MOUNTAIN VIEW, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial... Full story

Yahoo Finance • 2 years ago

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will be participati... Full story

Yahoo Finance • 3 years ago

NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022

MOUNTAIN VIEW, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will report finan... Full story